EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomaterial-based therapeutic strategies for oral submucous fibrosis

Yue Su, Yinyi Song, Fan Xue, Hanbing Wang, Zitong Zeng, Yourong Jiang

Frontiers in Cell and Developmental Biology · 24.08.2026 · 14

DOI: 10.3389/fcell.2026.1891450 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 24.08.2026. Verfasst von Yue Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Jining Medical University, Jining, China. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral submucous fibrosis (OSF) is a chronic, potentially malignant oral mucosal disease driven by areca nut chewing. It is characterized by progressive collagen deposition and debilitating symptoms such as trismus and burning sensation, which severely impair quality of life and confer a risk of malignant transformation. Given the limited efficacy of current therapies, this review aims to provide a comprehensive and critical appraisal of the evolving therapeutic landscape for OSF. We summarize conventional strategies, including pharmacological, surgical and physical approaches, alongside emerging therapeutic strategies, through a comprehensive literature review and screening of historical periodicals. The analysis reveals that established treatments have inherent limitations, whereas emerging approaches, including biomaterial-based delivery systems, nucleic acid and cell-based therapies, drug-loaded microneedle patches, and preventive interventions, show promise by overcoming poor mucosal retention, limited epithelial penetration and rapid salivary clearance. Mechanistic insights and the therapeutic potential of these strategies are discussed based on preclinical evidence. We conclude that current OSF therapies have limited efficacy, underscoring the need for innovative approaches. Emerging biomaterial-based systems and targeted drug delivery hold substantial potential, but further clinical research is essential to validate their safety and effectiveness for patient care.

Schlagwörter

Stichwörter der Autor:innen

biomaterialcell therapydrug delivery systemexosomeoral submucous fibrosis

Autor:innen und Institutionen

  • Department of Stomatology, Jining Medical University, Jining, China.

Zitieren

APA

Su, Y., Song, Y., Xue, F., Wang, H., Zeng, Z., & Jiang, Y. (2026). Biomaterial-based therapeutic strategies for oral submucous fibrosis. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1891450

Vancouver

Su Y, Song Y, Xue F, Wang H, Zeng Z, Jiang Y. Biomaterial-based therapeutic strategies for oral submucous fibrosis. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1891450

BibTeX
@article{Su2026,
  author = {Su, Yue and Song, Yinyi and Xue, Fan and Wang, Hanbing and Zeng, Zitong and Jiang, Yourong},
  title = {Biomaterial-based therapeutic strategies for oral submucous fibrosis},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1891450}
}
Kostenlos starten →